Opposite results were published by Feng L. et al., who concluded that IL-8 was significant in predicting shorter overall survival time, though this study followed up a cohort of patients with TNM III and IV pancreatic cancer, and the cut-off value was selected by the median of IL-8 expression [12]. Here, CXCL8 is linked to pancreatic neoplasm.